Weight-loss-drug makers’ stocks get a boost from new Biden coverage proposal, but will it hold up?

The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were higher across the board early Tuesday, after the Biden administration proposed a rule that would allow Medicare or Medicaid to cover the expensive medications.

Read more at MarketWatch

Save story

Topics

Related

Biden proposes huge expansion of US weight-loss drug coverage
World - Financial Times - 19 hours ago
Biden proposes weight loss drug coverage requirements for Medicare and Medicaid
Top stories - NBC News - 16 hours ago
Biden proposes expanded coverage for weight loss drugs under Medicare, Medicaid
Politics - NBC News - 14 hours ago
Biden proposes weight loss drug coverage by Medicare, Medicaid
Top stories - CBS News - 12 hours ago
Why Biden is proposing weight loss drug Medicare, Medicaid coverage
Top stories - CBS News - 11 hours ago
Biden’s plan for Medicare coverage of weight-loss drugs would drive up costs by billions of dollars
Business - MarketWatch - 5 hours ago

More from MarketWatch

Biden’s plan for Medicare coverage of weight-loss drugs would drive up costs by billions of dollars
Business - MarketWatch - 5 hours ago
Dell’s AI boost derailed slightly by Blackwell transition and slower move to AI PCs
Business - MarketWatch - 5 hours ago
Urban Outfitters says it doesn’t have to discount as aggressively, amid holiday-season optimism
Business - MarketWatch - 7 hours ago
CrowdStrike hits a sales milestone in first full quarter after sparking IT outage
Business - MarketWatch - 7 hours ago
PagerDuty says software customers are still being ‘prudent’ with their spending
Business - MarketWatch - 7 hours ago